{"id":58023,"date":"2026-02-26T16:20:14","date_gmt":"2026-02-26T08:20:14","guid":{"rendered":"https:\/\/flcube.com\/?p=58023"},"modified":"2026-02-26T16:20:14","modified_gmt":"2026-02-26T08:20:14","slug":"nmpa-approves-76-innovative-medical-devices-in-2025-17-yoy-growth-driven-by-ai-and-priority-review-surge","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=58023","title":{"rendered":"NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge"},"content":{"rendered":"\n<p>The <strong>National Medical Products Administration (NMPA)<\/strong> released its <strong>2025 Annual Medical Device Registration Report<\/strong>, highlighting <strong>accelerated innovation<\/strong> in China&#8217;s medical technology sector. The agency approved <strong>76 innovative medical devices<\/strong> in 2025, representing a <strong>17% year\u2011on\u2011year increase<\/strong>, with <strong>priority review approvals surging 212.5%<\/strong> to 25 devices. Approved products span <strong>artificial intelligence, radiation oncology, and biomedical materials<\/strong>, reflecting China&#8217;s advancing capabilities in cutting\u2011edge healthcare technology.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-2025-approval-statistics\">2025 Approval Statistics<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>2025<\/th><th>YoY Change<\/th><\/tr><\/thead><tbody><tr><td><strong>Total Innovative Device Approvals<\/strong><\/td><td><strong>76<\/strong><\/td><td><strong>+17%<\/strong><\/td><\/tr><tr><td>\u2014 Active Medical Devices<\/td><td>45<\/td><td>\u2014<\/td><\/tr><tr><td>\u2014 Passive Medical Devices<\/td><td>29<\/td><td>\u2014<\/td><\/tr><tr><td>\u2014 IVD Reagents<\/td><td>2<\/td><td>\u2014<\/td><\/tr><tr><td><strong>Priority Review Approvals<\/strong><\/td><td><strong>25<\/strong><\/td><td><strong>+212.5%<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-top-five-innovation-categories\">Top Five Innovation Categories<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Rank<\/th><th>Category<\/th><th>Growth Notes<\/th><\/tr><\/thead><tbody><tr><td>1<\/td><td>Active Surgical Instruments<\/td><td>Leading category<\/td><\/tr><tr><td>2<\/td><td>Passive Implantable Devices<\/td><td><strong>Rapid growth<\/strong> vs. 2024<\/td><\/tr><tr><td>3<\/td><td>Active Implantable Devices<\/td><td>Core cardiovascular\/neuro technology<\/td><\/tr><tr><td>4<\/td><td>Ophthalmic Devices<\/td><td><strong>Rapid growth<\/strong> vs. 2024<\/td><\/tr><tr><td>5<\/td><td>Neurological and Cardiovascular Surgical Instruments<\/td><td>High\u2011precision intervention tools<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-innovation-requirements\">Innovation Requirements<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Criterion<\/th><th>Standard<\/th><\/tr><\/thead><tbody><tr><td><strong>IP Protection<\/strong><\/td><td>Chinese invention patents or state\u2011disclosed patent applications<\/td><\/tr><tr><td><strong>Novelty<\/strong><\/td><td>Domestic pioneer in primary working principles\/mechanisms<\/td><\/tr><tr><td><strong>Clinical Value<\/strong><\/td><td>Significant therapeutic or diagnostic advancement<\/td><\/tr><tr><td><strong>Technology Focus<\/strong><\/td><td>AI, radiation oncology, biomedical materials, surgical robotics<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Innovation Acceleration:<\/strong> The <strong>17% approval growth<\/strong> and <strong>212.5% priority review surge<\/strong> signal NMPA&#8217;s commitment to <strong>streamlined pathways<\/strong> for breakthrough devices, reducing time\u2011to\u2011market for domestic innovators.<\/li>\n\n\n\n<li><strong>AI and Digital Health:<\/strong> Inclusion of <strong>artificial intelligence<\/strong> among top fields validates China&#8217;s <strong>AI\u2011enabled medical device strategy<\/strong>, spanning imaging, diagnostics, and surgical planning.<\/li>\n\n\n\n<li><strong>Implantable Device Growth:<\/strong> <strong>Rapid growth in passive implantables and ophthalmics<\/strong> reflects maturing domestic capabilities in <strong>structural heart, orthopedic, and vision restoration technologies<\/strong>.<\/li>\n\n\n\n<li><strong>IP and Pioneer Status:<\/strong> The <strong>patent protection and domestic pioneer requirements<\/strong> incentivize original R&amp;D while protecting against copycat products, fostering sustainable innovation ecosystems.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact\">Market Impact<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Stakeholder<\/th><th>Impact<\/th><\/tr><\/thead><tbody><tr><td><strong>Domestic Device Manufacturers<\/strong><\/td><td>Expanded market access for innovative products; priority review pathway reduces regulatory timeline<\/td><\/tr><tr><td><strong>Multinational Medtech<\/strong><\/td><td>Increased competition from domestic innovators; partnership and localization opportunities<\/td><\/tr><tr><td><strong>Healthcare Providers<\/strong><\/td><td>Broader access to advanced AI\u2011enabled and robotic surgical technologies<\/td><\/tr><tr><td><strong>Investors<\/strong><\/td><td>212.5% priority review growth signals regulatory support for medtech venture capital<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding 2026 approval trends, category growth projections, and market access expansion. Actual results may differ due to risks including regulatory policy shifts, competitive dynamics, and reimbursement negotiation challenges.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The National Medical Products Administration (NMPA) released its 2025 Annual Medical Device Registration Report, highlighting&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[14],"class_list":["post-58023","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The National Medical Products Administration (NMPA) released its 2025 Annual Medical Device Registration Report, highlighting accelerated innovation in China&#039;s medical technology sector. The agency approved 76 innovative medical devices in 2025, representing a 17% year\u2011on\u2011year increase, with priority review approvals surging 212.5% to 25 devices. Approved products span artificial intelligence, radiation oncology, and biomedical materials, reflecting China&#039;s advancing capabilities in cutting\u2011edge healthcare technology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=58023\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge\" \/>\n<meta property=\"og:description\" content=\"The National Medical Products Administration (NMPA) released its 2025 Annual Medical Device Registration Report, highlighting accelerated innovation in China&#039;s medical technology sector. The agency approved 76 innovative medical devices in 2025, representing a 17% year\u2011on\u2011year increase, with priority review approvals surging 212.5% to 25 devices. Approved products span artificial intelligence, radiation oncology, and biomedical materials, reflecting China&#039;s advancing capabilities in cutting\u2011edge healthcare technology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=58023\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-26T08:20:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58023#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58023\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge\",\"datePublished\":\"2026-02-26T08:20:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58023\"},\"wordCount\":368,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NMPA\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=58023#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58023\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=58023\",\"name\":\"NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-02-26T08:20:14+00:00\",\"description\":\"The National Medical Products Administration (NMPA) released its 2025 Annual Medical Device Registration Report, highlighting accelerated innovation in China's medical technology sector. The agency approved 76 innovative medical devices in 2025, representing a 17% year\u2011on\u2011year increase, with priority review approvals surging 212.5% to 25 devices. Approved products span artificial intelligence, radiation oncology, and biomedical materials, reflecting China's advancing capabilities in cutting\u2011edge healthcare technology.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58023#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=58023\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58023#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge - Insight, China&#039;s Pharmaceutical Industry","description":"The National Medical Products Administration (NMPA) released its 2025 Annual Medical Device Registration Report, highlighting accelerated innovation in China's medical technology sector. The agency approved 76 innovative medical devices in 2025, representing a 17% year\u2011on\u2011year increase, with priority review approvals surging 212.5% to 25 devices. Approved products span artificial intelligence, radiation oncology, and biomedical materials, reflecting China's advancing capabilities in cutting\u2011edge healthcare technology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=58023","og_locale":"en_US","og_type":"article","og_title":"NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge","og_description":"The National Medical Products Administration (NMPA) released its 2025 Annual Medical Device Registration Report, highlighting accelerated innovation in China's medical technology sector. The agency approved 76 innovative medical devices in 2025, representing a 17% year\u2011on\u2011year increase, with priority review approvals surging 212.5% to 25 devices. Approved products span artificial intelligence, radiation oncology, and biomedical materials, reflecting China's advancing capabilities in cutting\u2011edge healthcare technology.","og_url":"https:\/\/flcube.com\/?p=58023","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-02-26T08:20:14+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=58023#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=58023"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge","datePublished":"2026-02-26T08:20:14+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=58023"},"wordCount":368,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NMPA"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=58023#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=58023","url":"https:\/\/flcube.com\/?p=58023","name":"NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-02-26T08:20:14+00:00","description":"The National Medical Products Administration (NMPA) released its 2025 Annual Medical Device Registration Report, highlighting accelerated innovation in China's medical technology sector. The agency approved 76 innovative medical devices in 2025, representing a 17% year\u2011on\u2011year increase, with priority review approvals surging 212.5% to 25 devices. Approved products span artificial intelligence, radiation oncology, and biomedical materials, reflecting China's advancing capabilities in cutting\u2011edge healthcare technology.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=58023#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=58023"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=58023#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NMPA Approves 76 Innovative Medical Devices in 2025 \u2013 17% YoY Growth Driven by AI and Priority Review Surge"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=58023"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58023\/revisions"}],"predecessor-version":[{"id":58024,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58023\/revisions\/58024"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=58023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=58023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=58023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}